Metastatic lymph node burden impacts overall survival in submandibular gland cancer
ConclusionsThe effect of LN metastasis on OS and RFS was mainly determined by the number of positive LNs. A validation of this finding is warranted in adenoid cystic carcinomas that were not included in this study. (Source: Frontiers in Oncology)
Source: Frontiers in Oncology - November 14, 2023 Category: Cancer & Oncology Source Type: research
Rare but clinically important salivary gland-type tumor of the lung: A review
Jpn J Clin Oncol. 2023 Nov 10:hyad154. doi: 10.1093/jjco/hyad154. Online ahead of print.ABSTRACTSalivary gland-type tumor (SGT) of the lung, which arises from the bronchial glands of the tracheobronchial tree, was first recognized in the 1950s. SGT represents less than 1% of all lung tumors and is generally reported to have a good prognosis. Mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ACC) are the two most common subtypes, comprising more than 90% of all SGTs. The reported 5-year survival rate of patients with SGT is 63.4%. Because this type of tumor develops in major bronchi, patients with SGT commonly pr...
Source: Clinical Lung Cancer - November 12, 2023 Category: Cancer & Oncology Authors: Shinkichi Takamori Yasushi Yatabe Atsushi Osoegawa Keiju Aokage Hiroshige Yoshioka Tomohiro Miyoshi Takahiro Mimae Makoto Endo Aritoshi Hattori Masaya Yotsukura Tetsuya Isaka Mitsuhiro Isaka Tomohiro Maniwa Ryu Nakajima Shun-Ichi Watanabe Source Type: research
Rare but clinically important salivary gland-type tumor of the lung: A review
Jpn J Clin Oncol. 2023 Nov 10:hyad154. doi: 10.1093/jjco/hyad154. Online ahead of print.ABSTRACTSalivary gland-type tumor (SGT) of the lung, which arises from the bronchial glands of the tracheobronchial tree, was first recognized in the 1950s. SGT represents less than 1% of all lung tumors and is generally reported to have a good prognosis. Mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ACC) are the two most common subtypes, comprising more than 90% of all SGTs. The reported 5-year survival rate of patients with SGT is 63.4%. Because this type of tumor develops in major bronchi, patients with SGT commonly pr...
Source: Clinical Breast Cancer - November 12, 2023 Category: Cancer & Oncology Authors: Shinkichi Takamori Yasushi Yatabe Atsushi Osoegawa Keiju Aokage Hiroshige Yoshioka Tomohiro Miyoshi Takahiro Mimae Makoto Endo Aritoshi Hattori Masaya Yotsukura Tetsuya Isaka Mitsuhiro Isaka Tomohiro Maniwa Ryu Nakajima Shun-Ichi Watanabe Source Type: research
Rare but clinically important salivary gland-type tumor of the lung: A review
Jpn J Clin Oncol. 2023 Nov 10:hyad154. doi: 10.1093/jjco/hyad154. Online ahead of print.ABSTRACTSalivary gland-type tumor (SGT) of the lung, which arises from the bronchial glands of the tracheobronchial tree, was first recognized in the 1950s. SGT represents less than 1% of all lung tumors and is generally reported to have a good prognosis. Mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ACC) are the two most common subtypes, comprising more than 90% of all SGTs. The reported 5-year survival rate of patients with SGT is 63.4%. Because this type of tumor develops in major bronchi, patients with SGT commonly pr...
Source: Clinical Genitourinary Cancer - November 12, 2023 Category: Cancer & Oncology Authors: Shinkichi Takamori Yasushi Yatabe Atsushi Osoegawa Keiju Aokage Hiroshige Yoshioka Tomohiro Miyoshi Takahiro Mimae Makoto Endo Aritoshi Hattori Masaya Yotsukura Tetsuya Isaka Mitsuhiro Isaka Tomohiro Maniwa Ryu Nakajima Shun-Ichi Watanabe Source Type: research
Comparing Safety Profiles: Low-Temperature Plasma Excision vs. Traditional Adenoidectomy for Adenoid Hypertrophy
CONCLUSIONS: Low-temperature plasma excision performed under NE for AH demonstrates superior outcomes and improved surgical safety and is strongly recommended for the treatment of adenoid hypertrophy.PMID:37944959 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - November 9, 2023 Category: Complementary Medicine Authors: Xilan Gu Fang Liu Wenbin Wang Fei Ye Xiaodong Yin Source Type: research
